Arvinas, Inc. (ARVN)
13.13
+0.03
(+0.23%)
USD |
NASDAQ |
Dec 10, 15:04
Arvinas Profit Margin (Quarterly): -83.77% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 21.32% |
| Assembly Biosciences, Inc. | -85.24% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Verastem, Inc. | -876.3% |
| Sarepta Therapeutics, Inc. | -45.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.81% |
| Return on Assets | -5.83% |
| Return on Invested Capital | -9.68% |
| Gross Profit Margin (Quarterly) | 96.90% |
| Operating Margin (Quarterly) | -105.0% |
| Return on Net Operating Assets | -281.0% |